Cholera vaccine is 86 percent effective, study reports

May 29, 2014
Image credit: Wikipedia.

A cheap and easy to deliver oral vaccine against cholera is 86 percent effective in preventing the infection which causes severe diarrhea and can be fatal, researchers said Thursday.

Some 1.4 billion people around the globe were at risk for cholera in 2012, according to World Health Organization (WHO).

Cholera is caused by a bacterium, Vibrio cholerae, which can spread through the water supply in places where sanitation and hygiene are poor.

The study in the May 29 edition of the New England Journal of Medicine was the first to measure the effectiveness of a vaccine called Shanchol in response to a under field conditions in Guinea.

Previously, the vaccine had been tested only under experimental conditions in Kolkata, India.

The research in Guinea, carried out by Doctors Without Borders (Medecins Sans Frontieres), involved more than 300,000 doses of the two-dose vaccine, administered during a cholera outbreak in 2012.

It was 82 to 86 percent effective, and carried few side effects.

However, researchers were unable to compare one versus two doses in preventing cholera, and it remains unknown how the long the vaccine can remain effective at room temperature.

"Furthermore, can Shanchol be used in pregnancy and in children younger than one year of age?" asked a pair of doctors in Haiti and the United States, in an accompanying Perspective article in the journal.

"Although WHO recommendations suggest targeting pregnant women at high risk for cholera, the manufacturer has not approved use of the vaccine in pregnancy, and there are no guidelines for children under one year old."

There are three cholera vaccines currently on the world market.

Shanchol is less expensive and easier to store than another leading vaccine, Dukoral, and the two are comparable in terms of effectiveness.

Shanchol costs $1.85 per dose, compared to Dukoral at $5.25 per dose. Both may offer some protection against for up to five years.

The two vaccines have been approved by the World Health Organization for purchase by UN agencies. A third , mORCVAX, is licensed and produced only in Vietnam.

More than 1.6 million doses of Shanchol have already been distributed worldwide in the past three years.

The WHO has stockpiled two million doses and the Global Alliance for Vaccines and Immunization (GAVI) has pledged support for 20 million doses over the next five years, said the editorial, warning that millions more doses are needed.

Explore further: Haiti to test cholera vaccine

Related Stories

Haiti to test cholera vaccine

October 19, 2011
Haiti's health ministry is preparing to test a cholera vaccine on a hundred people, a year after an epidemic killed over 6,500 people, officials said Wednesday.

Pioneering use of oral cholera vaccine during outbreak

October 17, 2013
In a report publishing October 17th, 2013 in PLOS Neglected Tropical Diseases, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and its scientific research arm, ...

Vaccine confers long-term protection against cholera

October 16, 2013
A clinical study published in the Lancet Infectious Diseases shows for the first time that an oral cholera vaccine (ShancholTM) provides sustained protection against cholera in humans for up to five years. The study showed ...

UN: Haiti has more cholera than any other nation

March 24, 2014
Haiti's cholera outbreak is still the worst in the world, the top U.N. envoy there said Monday.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.